Insider · CIK 0001889967
Gabriel S Morris
Files at IMMX (Immix Biopharma, Inc.). First filing Jun 20, 2025, latest Dec 10, 2025.
In brief
Gabriel S Morris files SEC Form 4 as CFO, director and president at IMMX (Immix Biopharma, Inc.). Since Jun 20, 2025, Gabriel S Morris has reported 3 open-market buys worth $15k and 0 open-market sells worth $0, the latest filed on Dec 10, 2025.
A track record needs three past buys with six months of prices behind them; Gabriel S Morris has 0, so none is measured yet.
The newest scored trade: bought $5,067 of IMMX on Dec 10, 2025, filed Dec 10, 2025, scored 30 (weak). In the last 12 months: 1 buy worth $5,067 and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
IMMX: Immix Biopharma, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 30Weak | Immix Biopharma, Inc. | $5,067 770 shares | +0% | +395% from low0% from high | |
| 38Weak | Immix Biopharma, Inc. | $5,122 2,600 shares | +1% | +49% from low-33% from high | |
| 25Weak | Immix Biopharma, Inc. | $5,071 2,225 shares | +1% | +78% from low-8% from high |
Transactions
Every row this insider has filed, 8 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 22, 2026 | IMMX Immix Biopharma, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +500,000 | $0.00 | $0 | 500,000 | May 29, 2026 |
| Dec 8, 2025 | IMMX Immix Biopharma, Inc. | XIn-the-money exercise Common Stockindirect: See footnote | +156,000 | $0.80 | $125k | 426,844 | Dec 10, 2025 |
| Dec 10, 2025 | IMMX Immix Biopharma, Inc. | POpen-market purchase Common Stock | +770 | $6.58 | $5,067 | 291,429 | Dec 10, 2025 |
| Dec 8, 2025 | IMMX Immix Biopharma, Inc. | XIn-the-money exercise Warrants (right to purchase)derivativeindirect: See footnote | -96,000 | $0.00 | $0 | 0 | Dec 10, 2025 |
| Dec 8, 2025 | IMMX Immix Biopharma, Inc. | XIn-the-money exercise Warrants (right to purchase)derivativeindirect: See footnote | -60,000 | $0.00 | $0 | 0 | Dec 10, 2025 |
| Sep 16, 2025 | IMMX Immix Biopharma, Inc. | POpen-market purchase Common Stock | +2,600 | $1.97 | $5,122 | 290,659 | Sep 17, 2025 |
| Jun 20, 2025 | IMMX Immix Biopharma, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +340,000 | $0.00 | $0 | 340,000 | Jun 23, 2025 |
| Jun 18, 2025 | IMMX Immix Biopharma, Inc. | POpen-market purchase Common Stock | +2,225 | $2.28 | $5,071 | 288,059 | Jun 20, 2025 |
Questions about Gabriel S Morris
Answered from the filings on this page, as of the latest one.
Is Gabriel S Morris buying or selling?
In the last 12 months Gabriel S Morris reported 1 open-market buy worth $5,067 and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $5,067 of IMMX on Dec 10, 2025. Grants, option exercises and tax withholding are not counted.
How did Gabriel S Morris's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Gabriel S Morris has 0.
Where does Gabriel S Morris file Form 4?
Gabriel S Morris has filed Form 4 at IMMX (Immix Biopharma, Inc.) as CFO, President. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.